What are IME listings?
This article provides an overview of Important Medical Event (IME) listings, their development, and their role in pharmacovigilance.
This article provides an overview of Important Medical Event (IME) listings, their development, and their role in pharmacovigilance.
A simplified guide to causality assessment in pharmacovigilance, covering WHO-UMC classifications and key criteria for evaluating adverse drug reactions.
This article simplifies key compliance concepts, highlights practical do’s and don’ts, and provides essential insights to help case processors and newcomers.
This article explores the fundamentals of pharmacovigilance case management, key industry trends, and practical strategies—including automation and AI.
This article explores the different types of pharmacovigilance service providers, the factors to consider when selecting one though your process.
Literature screening is a fundamental step in pharmacovigilance literature management. So here we explain an overview of understanding the process.
Causality assessment is one of the most critical and challenging tasks in pharmacovigilance. It requires more than simply linking an adverse event to a drug.
Assessing ADR-AE (Adverse Drug Reactions and Adverse Events) are more than regulatory terminology—so it is necessary to report rightly. so here we explore.
Copyright © Drugvigil. All Rights Reserved.